Skip to main content
Clinical Trials/NCT05812443
NCT05812443
Active, not recruiting
Not Applicable

Assessment of Sleep Quality and Mental Health After Using Meditation: a Randomized Controlled Trial

Federal University of Minas Gerais1 site in 1 country174 target enrollmentApril 10, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Insomnia
Sponsor
Federal University of Minas Gerais
Enrollment
174
Locations
1
Primary Endpoint
Mean Sleep Efficiency Change
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

This is a randomized controlled trial that intends to verify the effectiveness of the daily practice of meditation before going to sleep for the improvement of sleep, stress, mental health and quality of life of people with sleep problems.

Detailed Description

Participants selected for this clinical trial will be randomized into two groups: group 1 (intervention), with 87 participants undergoing 30 minutes of Shabad Kriya meditation before going to sleep, and group 2 (control), with 87 participants who will perform 30 minutes of relaxing reading before going to sleep. In addition, participants will complete the demographic data form; a sleep quality diary; and the scales: Pittsburgh Sleep Quality Index (PSQI), Perceived Stress Scale (PBS), Five Facets of Mindfulness (FFMQ), Daily Spiritual Experiences (DSES), Functional Assessment of Chronic Illness Therapy - Wellness Scale Spiritual (FACIT- 12), Duke Religiosity Index (DUREL), Quality of Life - Brief Mode (WHOQOL-Bref) and the Depression, Anxiety and Stress Scale (DASS 21). The study is open to the general community, and those interested are screened through the "Insomnia Severity Index" and questionnaires about health conditions. For conducting and guiding the intervention and completing the research instruments, online meetings will be held with the participants. The sleep quality diary will be completed for fourteen days before the start of the intervention (Baseline). Data collection will be carried out with online Google Forms questionnaires, sent through links in digital media, such as messages or emails, or made available in printed form. The main outcome measure will be sleep efficiency calculated using data from the sleep diary. Data from participants with ISI greater than or equal to 10 will be compared before and after the intervention. Additionally, data analysis of participants with ISI above or greater than 8 will be performed. At the end of the eighth week of the intervention (Shabad Kriya meditation or Relaxing reading), as well as one month after the end of the intervention, and three months after the end of the intervention, the participants will again fill in the questionnaires described above, for statistical comparisons.

Registry
clinicaltrials.gov
Start Date
April 10, 2023
End Date
March 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Federal University of Minas Gerais
Responsible Party
Principal Investigator
Principal Investigator

Rubens Lene Carvalho Tavares

Professor

Federal University of Minas Gerais

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of insomnia (Insomnia Severity Index between 8-28)

Exclusion Criteria

  • Major medical or psychiatric problems
  • Who has used sleeping pills or sleep-disrupting medications in the last 30 days prior to participating in the study
  • Who will need to use sleeping pills or sleep-disrupting medications during the study

Outcomes

Primary Outcomes

Mean Sleep Efficiency Change

Time Frame: Baseline (T1), after 8 weeks of intervention (T2), 4 weeks after the end of the intervention (T3), and 12 weeks after the end of the intervention (T4)

Sleep efficiency is calculated as the number of hours asleep divided by the number of hours in bed with the intention to sleep. Sleep efficiency will be calculated from online sleep diaries that will be completed by participants in this study at baseline (T1), immediately after after 8 weeks of intervention (T2), 1 month (T3) and 3 months (T4) after intervention. Sleep efficiency is calculated using sleep parameters extracted from these diaries as sleep onset latency (SOL), total sleep time (TST), total wake time (TWT), Wake After Sleep Onset (WASO).

Secondary Outcomes

  • Duke University Religion Index (DUREL) Change(Baseline (T1), after 8 weeks of intervention (T2), 4 weeks after the end of the intervention (T3), and 12 weeks after the end of the intervention (T4))
  • Insomnia Severity Index (ISI) Change(Baseline (T1), after 8 weeks of intervention (T2), 4 weeks after the end of the intervention (T3), and 12 weeks after the end of the intervention (T4))
  • Pittsburgh Sleep Quality Index (PSQI) Change(Baseline (T1), after 8 weeks of intervention (T2), 4 weeks after the end of the intervention (T3), and 12 weeks after the end of the intervention (T4))
  • Self-Reported Quality of Life Change(Baseline (T1), after 8 weeks of intervention (T2), 4 weeks after the end of the intervention (T3), and 12 weeks after the end of the intervention (T4))
  • Depression Anxiety Stress Scale (DASS)-21 Change(Baseline (T1), after 8 weeks of intervention (T2), 4 weeks after the end of the intervention (T3), and 12 weeks after the end of the intervention (T4))
  • Five Facet Mindfulness Questionnaire (FFMQ-BR) Change(Baseline (T1), after 8 weeks of intervention (T2), 4 weeks after the end of the intervention (T3), and 12 weeks after the end of the intervention (T4))
  • Functional Assessment of Chronic Illness Therapy (FACIT-Sp-12) Change(Baseline (T1), after 8 weeks of intervention (T2), 4 weeks after the end of the intervention (T3), and 12 weeks after the end of the intervention (T4))
  • Daily spiritual experiences scale (DSES) Change(Baseline (T1), after 8 weeks of intervention (T2), 4 weeks after the end of the intervention (T3), and 12 weeks after the end of the intervention (T4))
  • The Perceived Stress Scale (PSS) Change(Baseline (T1), after 8 weeks of intervention (T2), 4 weeks after the end of the intervention (T3), and 12 weeks after the end of the intervention (T4))

Study Sites (1)

Loading locations...

Similar Trials